Year: 2016
Type: editorial
Abstract: With the increasing appreciation for the toxicity of acute myeloid leukemia (AML) therapies, interest grows in measuring treatment benefits not only with regard to quantity of life but also quality...
Source: Expert Review of Hematology
Institutions: University of Washington, Fred Hutch Cancer Center
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: G4523881014, G834931733
OpenAlex ID: W2473134996
